Increased AAI mode pacing threshold after termination of atrial fibrillation by acute administration of disopyramide phosphate

Europace

Volumn 8, Issue 5, 2006, Pages 345-348

  Anzawa, R ^a   Ishikawa, S ^a,b   Tanaka, Y ^a   Okazaki, F ^a   Mochizuki, S ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tsunan Hospital   (Japan)

Author keywords

Antiarrhythmic drug; Atrial fibrillation; Disopyramide phosphate; Pacing failure; Pacing threshold; Sick sinus syndrome

Indexed keywords

BISOPROLOL; CREATININE; DISOPYRAMIDE PHOSPHATE; METOPROLOL; POTASSIUM;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD SAMPLING; BRADYCARDIA; CASE REPORT; DRUG BLOOD LEVEL; ELECTROCARDIOGRAM; ENZYME IMMUNOASSAY; FEMALE; HEART ATRIUM FIBRILLATION; HEART PACING; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; QT INTERVAL; SICK SINUS SYNDROME; SPHYGMOMANOMETER; UNSPECIFIED SIDE EFFECT;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; DISOPYRAMIDE; FEMALE; HUMANS; MALE; MIDDLE AGED; SICK SINUS SYNDROME; TREATMENT OUTCOME;

EID: 33745345900     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eul020     Document Type: Article

References (21)

1. Bianconi L, Boccadamo R, Toscano S, Serdoz R, Carpino A, Iesi AP et al. Effects of oral propafenone therapy on chronic myocardial pacing threshold. Pacing Clin Electrophysiol 1992;15:148-54.
2. Hellestrand KJ, Nathan AW, Bexton RS, Camm AJ. Electrophysiologic effects of flecainide acetate on sinus node function, anomalous atrioventricular concentrations and pacemaker thresholds. Am J Cardiol 1984;53:30B-8B.
3. Hellestrand KJ, Burnett PJ, Milne JR, Bexton RS, Nathan AW, Camm AJ. Effect of the antiarrhythmic agent flecainide acetate on acute and chronic pacing threshold. Pacing Clin Electrophysiol 1983;6:892-9.
4. Antonelli D, Freedberg NA, Rosenfeld T. Acute loss of capture due to flecainide acetate. Pacing Clin Electrophysiol 2001;24:1170.
5. Haga M, Mizutani N, Mori M, Ota T, Wakida Y, Kobayashi T et al. Effects of antiarrhythmic agent on acute and chronic pacing thresholds. Pacing Clin Electrophysiol 1993;16:1603.
6. Preston TA, Fletcher RD, Lucchesi BR, Judge RD. Changes in myocardial threshold. Physiologic and pharmacologic factors in patients with implanted pacemakers. Am Heart J 1967;74:235-42.
7. Hayler AM, Holf DW, Volans GN. Fatal overdose with disopyramide. Lancet 1978;1:968-70.
8. Anzawa R, Ishikawa S, Tanaka Y, Okazaki F, Mochizuki S. Atrial pacing failure following termination of atrial fibrillation by acute administration of disopyramide phosphate. J Interv Cardiac Electrophysiol 2005;13:51-3.
9. Nielsen JC, Bottcher M, Nielsen TT et al. Regional blood flow in patients with sick sinus syndrome randomized to long-term single chamber atrial or dual chamber pacing - effect of pacing mode and rate. J Am Coll Cardiol 2000;35:1453-61.
10. Dohrmann ML, Goldschlanger NF. Myocardial stimulation threshold in patient with cardiac pacemakers: Effect of physiologic variables, pharmacologic agents and lead electrodes. Clin Cardiol 1985;3:527-37.
11. Nielsen AP, Griffin JC, Herre JM. Effect of amiodarone on acute and chronic pacing thresholds. Pacing Clin Electrophysiol 1984;7:462.
12. Camardo JS, Greenspan AM, Horowitz LN, Spielman SR, Josephson ME. Strength-interval relation in the human ventricle: Effect of procainamide. Am J Cardiol 1980;45:856-60.
13. Mohan JC, Kaul U, Bhatia ML. Acute effects of anti-arrhythmic drugs on cardiac pacing threshold. Acta Cardiol 1984;39:191-201.
14. Montefoschi N, Boccadamo R. Propafenone-induced acute variation of chronic atrial pacing threshold: A case report. Pacing Clin Electrophysiol 1990;13:480-3.
15. Numata T, Abe H, Nagatomo T, Kohshi K, Nakashima Y. Ventricular pacing failure after a single oral dose of pilsicainide in a patient with a permanent pacemaker and paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000;28:1436-8.
16. Niarchos AP. Disopyramide: Serum level and arrhythmia conversion. Am Heart J 1976;92:57-64.
17. Waller C, Callies F, Langenfeld H. Adverse effects of direct current cardioversion on cardiac pacemakers and electrodes. Is external cardioversion contraindicated in patients with permanent pacing systems? Europace 2004;6:165-8.
18. Soriano J, Almendral J, Arenal A, San Roman D, Delcan JL, Josephson ME. Rate-dependent failure of ventricular capture in patients treated with oral propafenone. Eur Heart J 1992;13:269-74.
19. Raitt MH, Kusumoto W, Giraud G, McAnulty JH. Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol 2004;15:507-12.
20. Creamer JE, Nathan AW, Sherman A et al. Acute and chronic effects of sotalol and propranolol on ventricular repolarization using constant rate pacing. Am J Cardiol 1986;57:1092.
21. Irnich W. The chronaxie time and its practical importance. Pacing Clin Electrophysiol 1980;3:292-301.